Technology being developed at Washington State University provides a non-invasive approach for diagnosing prostate cancer and tracking the disease’s progression.
The innovative filter-like device isolates prostate cancer indicators from other cellular information in blood and urine. It could enable doctors to determine how cancer patients are responding to different treatments without needing to perform invasive biopsies.
“It may be possible to predict which drugs would be most effective in treating a patient’s cancer,” said WSU chemistry professor Clifford Berkman. “More broadly, this technology could be expanded to other types of cancers and diseases.”